Smith & Nephew plc (LON:SN)’s share price was down 1% on Thursday . The stock traded as low as GBX 1,309 ($17.62) and last traded at GBX 1,310 ($17.63). Approximately 2,642,030 shares changed hands during mid-day trading, a decline of 9% from the average daily volume of 2,900,000 shares. The stock had previously closed at GBX 1,322.89 ($17.80).
Several equities analysts have recently weighed in on SN shares. Deutsche Bank reiterated a “buy” rating on shares of Smith & Nephew in a research note on Friday, October 13th. Jefferies Group reiterated a “buy” rating and issued a GBX 1,515 ($20.39) target price on shares of Smith & Nephew in a research note on Thursday, October 12th. Berenberg Bank reiterated a “hold” rating and issued a GBX 1,340 ($18.03) target price on shares of Smith & Nephew in a research note on Friday, November 3rd. J P Morgan Chase & Co reduced their target price on shares of Smith & Nephew from GBX 1,382 ($18.60) to GBX 1,369 ($18.43) and set a “neutral” rating for the company in a research note on Monday, November 13th. Finally, Goldman Sachs Group restated a “neutral” rating and issued a GBX 1,380 ($18.57) price objective on shares of Smith & Nephew in a research report on Monday, September 11th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of GBX 1,315.82 ($17.71).
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.